Abbas, Abdallah http://orcid.org/0000-0002-9035-5475
O’Byrne, Ciara http://orcid.org/0000-0001-5172-0030
Fu, Dun Jack http://orcid.org/0000-0003-2852-6912
Moraes, Gabriella http://orcid.org/0000-0003-3358-5861
Balaskas, Konstantinos
Struyven, Robbert
Beqiri, Sara
Wagner, Siegfried K. http://orcid.org/0000-0003-4915-4353
Korot, Edward http://orcid.org/0000-0002-5687-1564
Keane, Pearse A. http://orcid.org/0000-0002-9239-745X
Funding for this research was provided by:
moorfields eye charity career development award (R190028A)
uk research & innovation future leaders fellowship (MR/T019050/1)
moorfields eye hospital nhs foundation trust
Article History
Received: 28 June 2021
Revised: 10 November 2021
Accepted: 27 December 2021
First Online: 5 February 2022
Declarations
:
: Health Research Authority (HRA) and Health and Care Research Wales (HCRW) Approval has been given for this study. All research adhered to the tenets of the Declaration of Helsinki.The requirement for informed consent was waived by the Moorfields Eye Hospital review and ethics committee because this is the standard for use of retrospective, de-identified data for research within the United Kingdom National Health Service.
: The authors declare no competing interests.
: Dr Keane has acted as a consultant for DeepMind, Roche, Novartis, Apellis, and BitFount and is an equity owner in Big Picture Medical. He has received speaker fees from Heidelberg Engineering, Topcon, Allergan, and Bayer. Dr Keane is supported by a Moorfields Eye Charity Career Development Award (R190028A) and a UK Research & Innovation Future Leaders Fellowship (MR/T019050/1).Dr Fu is supported by Moorfields Eye Hospital and has acted as a consultant for Abbvie, Allergan, DeepMind. Dr. Korot has acted as a consultant for Genentech, Alimera, and Google Health, and is an equity owner in Reti Health. He was previously supported by the Moorfields Eye Charity Springboard Grant R190016A. All other authors have no disclosures.